LEXINGTON, Ky. (Dec. 7, 2022) — The University of Kentucky Markey Cancer Center has received renewed funding from the American Cancer Society (ACS) to support a long-standing faculty research program.
Credit: Photo by University of Kentucky College of Engineering
LEXINGTON, Ky. (Dec. 7, 2022) — The University of Kentucky Markey Cancer Center has received renewed funding from the American Cancer Society (ACS) to support a long-standing faculty research program.
The ACS’ Institutional Research Grant (IRG) is intended to help junior faculty establish and advance cancer research programs. The grant provides seed money to new investigators to initiate research projects and obtain preliminary results that help them build their programs and successfully compete for extramural funding.
The $360,000 grant will support a total of nine $40K pilot awards over the three-year funding period, which begins in January 2023.
The award is a renewal of the UK Markey Cancer Center’s IRG, which has been continuously funded since 1985.
“The ACS IRG has helped several UK faculty members advance their research programs over the past few decades,” said IRG principal investigator Kathleen O’Connor, Ph.D., a professor in the UK College of Medicine’s Department of Molecular and Cellular Biochemistry and associate director of cancer education and mentoring at UK Markey Cancer Center.
“The success of our previous ACS IRG awardees in obtaining extramural funding is a testament to the value this program has to advance cancer research,” O’Connor said. “The IRG program has helped to launch impactful research across a number of disciplines required to make progress against cancer including prevention, drug development, biology of cancer cells and health disparities.”
With the IRG funds, Markey will continue to host internal grant competitions for faculty. Three pilot awards will be granted each year for the next three years, with the next cycle opening for applications in early 2023.
Grant applications are reviewed by a panel of UK faculty with expertise in all areas of cancer research. The process will select grants with the highest scientific merit and greatest likelihood of obtaining extramural funding.
Markey’s IRG renewal was announced by the ACS in October, when they approved funding for 89 new Extramural Discovery Science research grants totaling $54.3 million.
The ACS IRG also allows Markey to compete for a Diversity in Cancer Research internship program grant, which has supported the Markey Science Training in Oncology, Networking and professional Growth (STRONG) Scholars Program over the past two years.
The University of Kentucky is increasingly the first choice for students, faculty and staff to pursue their passions and their professional goals. In the last two years, Forbes has named UK among the best employers for diversity, and INSIGHT into Diversity recognized us as a Diversity Champion four years running. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. UK has been judged a “Great College to Work for” three years in a row, and UK is among only 22 universities in the country on Forbes’ list of “America’s Best Employers.” We are ranked among the top 10 percent of public institutions for research expenditures — a tangible symbol of our breadth and depth as a university focused on discovery that changes lives and communities. And our patients know and appreciate the fact that UK HealthCare has been named the state’s top hospital for five straight years. Accolades and honors are great. But they are more important for what they represent: the idea that creating a community of belonging and commitment to excellence is how we honor our mission to be not simply the University of Kentucky, but the University for Kentucky.